/dl 2 (5) are among risk factors of persistent HPT. Furthermore, existence of nodular hyperplasia in parathyroid glands along with low weight has been showed to engage in persistent HPT (6) . Regarding to pathophysiology of bone involvement in persistent HPT, it has been pointed out that sclerostin, an osteocyte-secreted requisite for osteoblast development, decreases by high PTH levels and augments after parathyroidectomy (7) . Besides, identifying bone health parameters (density, microarchitecture, and mechanical properties) helps to recognize patients at high risk of post-transplantation fractures (8) . There are also rare cases of calciphylaxis after kidney transplantation accompanied by persistent HPT (9).
Management
Paricalcitol prescription has not negative effects on kidney function (10) . It decreases intact PTH and increases bone mineral density in recently transplanted kidney recipients (11) . However, it is not accompanied by advantages on osteopenia (12) . Cinacalcet has been recommended to manage posttransplantation persisted HPT (13) (14) (15) (16) (17) . Pre-transplant prescription has been recommended by others, demonstrating that pre-transplant administration of Implication for health policy/practice/research/medical education Identifying bone disorders after kidney transplantation, their risk factors and managements is a great challenge. One of them, persistent hyperparathyroidism, has been focused here.
Keywords: Hyperparathyroidism, kidney transplantation, cinacalcet, parathyroidectomy cinacalcet was considerably allied with reduced posttransplant hyperparathyroidism (18) . Parathyroidectomy has been suggested by others as a harmless process (19) and in long-term there was no significant difference between them and cinacalcet using group (20) . There is also an interesting report of rigorous bone loss with persistent HPT in a kidney recipient efficiently managed by Denosumab and vitamin D combination (21) .
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